Lesson plan

Ellipta

Ellipta is part of GlaxoSmithKline's trade names of several inhalable asthma and chronic obstructive airway disease (COPD) combination medications that make use of the same type of inhaler: * Fluticasone furoate (Arnuity Ellipta, Relvar Ellipta) * Fluticasone furoate/vilanterol (Breo Ellipta, Relvar Ellipta) * Fluticasone furoate/umeclidinium bromide/vilanterol (Trelegy Ellipta) * Umeclidinium bromide (Incruse Ellipta) * Umeclidinium bromide/vilanterol (Anoro Ellipta)

Back to article

Article summary

Ellipta is part of GlaxoSmithKline's trade names of several inhalable asthma and chronic obstructive airway disease (COPD) combination medications that make use of the same type of inhaler: * Fluticasone furoate (Arnuity Ellipta, Relvar Ellipta) * Fluticasone furoate/vilanterol (Breo Ellipta, Relvar Ellipta) * Fluticasone furoate/umeclidinium bromide/vilanterol (Trelegy Ellipta) * Umeclidinium bromide (Incruse Ellipta) * Umeclidinium bromide/vilanterol (Anoro Ellipta)

Key claims

No claims recorded.

Discussion questions

  1. Summarise the article in your own words. Which single claim would you verify first, and why?
  2. Which claim in this article is most likely to be revised as the sources update? How would you check its current status?
  3. If two sources disagreed about one of these facts, what would you need in order to trust one over the other?

Bibliography

No sources recorded.

Key claims and bibliography are generated from the same tracked claims and sources as the article page.